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moved towards the positive electrode.  These lanes did not show any unreacted Hb. 
Figure 1.3.  TEM images of Hb-PAA(100) and Hb-PAA(1000) samples synthesized at pH 6, 7 
or 8 after ruthenium oxide staining: a) Hb-PAA(100)-6, b) Hb-PAA(100)-7, c) Hb-PAA(100)-8, 
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Figure 1.6. (a) The peroxidase-like activities of Hb-PAA(100)-6 (green curve), Hb, (black 
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen 
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4 
buffer, pH 7.2). (b) The peroxidase-like activities of Hb-PAA(1000)-7 (green curve), Hb, (black 
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen 
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4 
buffer, pH 7.2). (c) Comparison of the specific activities of Hb-PAA nanoparticles with that of 
Hb and physical mixtures, all measured at room temperature, 1 µM protein, 2.5 mM guaiacol and 
1 mM H2O2 in 20 mM Na2HPO4 buffer, pH 7.2.  
 
Figure 1.7.  Lineweaver-Burk plots for the peroxidase-like activities of Hb-PAA(100)-6 (black 
dots), Hb-PAA(100)-7 (red dots).  Lines are best fits to the data using the Lineweaver-Burk 
equation.  All reactions were carried out in the presence of 1 µM Hb-PAA(100)-6 or Hb-
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7.2, room temperature. 
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activities of: (a) Hb-PAA nanoparticles compared with those of Hb, Hb/PAA physical mixtures 
which are also treated similarly, and (b) polyamine crosslinked Hb-PAA(1000)-8 nanoparticles 
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Figure 1.11.  Agarose gel (0.5%) of Hb (lane 1), Hb-PAA(1000) (lane 2), and Hb-PAA(1000)-
teta (lanes 3-6) synthesized in phosphate buffer, pH 8.  The samples were spotted at the bottom 
of the gel (running buffer, 40 mM Tris acetate pH 7.2).  While Hb moved as a streak (lane 1, 
faint band), Hb-PAA(1000)-8 (lane 2) and Hb-PAA(1000)-teta (lanes 3-6, crosslinked with 60, 
40, 20 and 10 mM teta, respectively) showed single bands. Hb-PAA(1000)-teta crosslinked 
nanoparticles moved lesser toward the positive electrode than Hb-PAA(1000)-8 due to 
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Figure 1.12 (a-c). Absorbance spectra of Hb-PAA(1000)-8-polyamine conjugates before heat 
denaturation at room temperature (blue curve), during denaturation at 90 ˚C (red curve) and after 
cooling back to room temperature (green curve), panels as labeled.  Thermal denaturation clearly 
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Cat-PAA(1000) (lane 3), Cat-PAA(1500) (lane 2) and Cat-PAA(2000) (lane 1). The conjugates 
used here were synthesized at pH 8. All samples were spotted in the center of the gel (0.5% 
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unreacted catalase in the lanes. 
 
Figure 2.2. Agarose gel of GOx (lanes 1 and 12) and GOx-PAA conjuagtes (lanes 2-11). The 
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Figure 2.3. Agarose gel of lysozyme (lane 2) and Lys-PAA(100)-7 (lane 1). The unmodified 
lysozyme migrated towards the negative electrode, which means that the unmodified lysozyme 
has a net positive charge. The Lys-PAA(100) migrated towards the positive electrode and do not 
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Figure 2.4. The decomposition activity of hydrogen peroxide by catalase (blue curve) and Cat-
PAA(1000)-8 (green curve). All activity data was measured at room temperature in the presence 
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Figure 2.5. (a) Kinetics traces for GOx (red curve) and GOx-PAA conjugate samples (glucose 
(0.2 mM), GOx (0.5 µM), HRP (2 µM) and guaiacol (10 mM) in 20 mM Na2HPO4, pH 7.2). (b) 
Comparison of relative activities of the GOx-PAA conjugates with that of the unmodified GOx 
at room temperature under the same reaction conditions. 
 
Figure 2.6. Kinetic traces for Lysozyme (red curve) and Lys-PAA(100)-6 (blue curve). Activity 
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Chapter 1 
Ultra-Stable Hemoglobin-Poly(Acrylic Acid) Conjugates 
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1.1  Abstract 
 
Stabilization of proteins against thermal deactivation is a major challenge, and a simple, facile, 
novel chemical approach is described here to overcome this hurdle.  We report here, for the first 
time, the successful synthesis of ultrastable protein nanoparticles consisting of met-hemoglobin 
(Hb) conjugated with low molecular weight poly(acrylic acid) (PAA, Mw 8,000) to form discrete 
nanoparticles.  Hb-PAA nanoparticles were not deactivated when subjected to prolonged thermal 
treatment such as steam sterilization conditions (122 ˚C, 40 minutes, 17-20 psi), while the 
unprotected Hb lost most of its activity, when subjected to the same heating conditions.  Several 
Hb-PAA derivatives which resist thermal inactivation, in a similar manner, are produced and 
characterized.  Interestingly, the highest activity retention, after the above thermal treatment, was 
~100% of the untreated samples.  This resistance to heat is attributed to the enhanced 
thermodynamic stability of the Hb-PAA conjugate and improved re-folding of the denatured 
state to the native form, facilitated by PAA conjugation to Hb.  This is a unique approach to 
stabilize Hb against thermal inactivation, and it is a major breakthrough in the production of 
stable Hb-based nanomaterials that can be safely sterilized in an autoclave for biomedical/in vivo 
applications. 
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1.2  Introduction 
 
 Improving protein thermal stability is a fundamental problem that is being intensely 
investigated,
1,2
 and steam sterilization conditions provide a bench-mark to evaluate the success 
of the strategies used for protein stabilization.  Steam sterilization of proteins causes extensive 
loss of their biological activity. This is a serious drawback for applications that require 
sterilization,
 3,4,5
 and protein stabilization against steam sterilization has been an elusive goal, so 
far.  However, it is imperative to improve proteins’ resistance to steam sterilization since this 
technique is more commonly available in most laboratories for sterilization using an ordinary 
autoclave, effective, and inexpensive to perform. Even the highly stable thermophilic proteins 
are deactivated by steam sterilization and proteins designed by rational approaches are 
promising, but so far they met with only limited success in this regard.
6
  Enhanced thermal 
stability is also important for improved storage stability of proteins under different 
environmental temperatures as well as for biocatalytic applications at high temperatures where 
the reactions can be further accelerated.  To date, there have been no established theoretical or 
experimental approaches to stabilize proteins against steam sterilization and this important goal 
of protein thermal stability needs to be achieved.
7,8
  
Protein-polymer nanosystems that are not deactivated by extreme heat, provide unique 
avenues to mass-produce thermally stable, steam-sterilizable biomaterials and products.
9,10
  
Suitably designed protein-polymer nanosystems can address this important issue by exploiting 
and synergistically combining favorable materials aspects of polymers such as their high thermal 
stability with the desired biological activities of proteins.
11
  The attachment of strongly 
hydrophilic polymers such as polyethylene glycol (PEG) to proteins are suggested to stabilize 
 4 
  
proteins against denaturation or loss of its three dimensional structure, but only limited progress 
has been made in terms of improved thermal stability,
12,13,14, 15,16
 but none of these examples 
demonstrated resistance to deactivation against thermal treatments such as steam sterilization.  
Several conjugates showed significant retention of activity and improved storage stability but 
these also did not indicate resistance against steam sterilization or high temperature biocatalytic 
activities.
17,18
  Although constructing a nanoporous wall around the protein was expected to 
improve protein stability,
19
 resistance of the nanoconjugate to heat denaturation has not been 
evaluated.  There are no known examples of general methodologies to stabilize proteins against 
steam sterilization via conjugation with polymers or otherwise, and overcoming this major 
hurdle could have a significant impact on a variety of applications of proteins as biomaterials, 
especially those that require sterilization, high temperature performance or long term stability.  
Here, we constructed novel protein-polymer nanoparicles and tested them for their thermal 
stability against steam sterilization conditions, as a bench mark to evaluate their thermal stability. 
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Scheme 1.1. (Top) Irreversible denaturation, conversion of the native state of the protein (N) to 
the corresponding denatured state (D), at the thermal denaturation temperature (Td).  (Bottom) 
Resistance to thermal deactivation can be achieved by stabilizing the native state with a suitable 
polymer (red lines) and/or by facilitating the denatured state to re-fold to the native state 
(reversible denaturation). 
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Our hypothesis is that stability can be improved by wrapping the protein in a soft, 
hydrophilic, water-soluble, flexible, polyelectrolyte where the hydrophilic polymer chains 
improve thermal stability of the protein.  Improvement in stability can be due to two factors, 1) 
decrease in the conformational entropy of the native state (N) of the protein due to its 
encapsulation in the polymer matrix, thereby increasing intrinsic thermal stability of the protein; 
and 2) enhanced solubility of the denatured state (D) due to the covalently-bound hydrophilic 
polymer chains, which can inhibit aggregation of the denatured peptide and facilitate refolding 
back to the native state.  Therefore, even if the protein undergoes thermal denaturation under 
steam sterilization conditions (122 ˚C, 40 min, 17-20 psi), in principle, it could re-fold into the 
native conformation and regain its biological activity, Scheme 1.  This hypothesis has been tested 
in the current studies. 
We successfully show that covalent linking of the carboxyl functions of a water-soluble 
anionic polymer to a model protein (Scheme 2) resulted in protein-polymer conjugates that resist 
deactivation by steam sterilization conditions. 
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Scheme 1.2.  The design of protein-polymer nanoparticles by covalent linking of the amino 
groups of hemoglobin (Hb) with the carboxyl functions of low molecular weight poly(acrylic 
acid) (PAA, MW 8000). Crosslinking of the polymer layer with ethylenediamine (en), 
triethylenetetrammine (teta) or tetraethylenpentamine (tepa) to further stiffen the polymer 
chains, and enhance resistance to thermal deactivation under steam sterilization conditions. 
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We have chosen poly(acrylic acid) (PAA) as the water-soluble, flexible, anionic polymer 
and methemoglobin (Hb)
 20,21
 as a model protein with multiple amino groups to test the above 
strategy. Improving Hb stability to steriliztion is important because it has the potential to be used 
as a biocompatible artificial blood substitute or as a biocatalyst with improved thermal stability. 
Hb has been linked to PEG, or entrapped in liposomes and vesicles to improve its stability and 
potential as a blood substitute.
22,23
  Use of Hb as an artificial blood substitute, however, would 
require retention of its biofunction after sterilization and long term storage stability.
24
   
Previously, we have shown that random crosslinking of a high molecular weight PAA 
(MW 450,000) with Hb results in soluble, Hb-PAA nanogels.
17 
 Careful and systematic 
evaluation of the nanogels showed that Hb encased in the polymer matrix retained its biological 
structure and activities, and that the crosslinking has been benign.  However, the nanogels did 
not indicate considerable improvement in thermal stability or protection against steam 
sterilization. 
In sharp contrast, the data presented here shows that protein stability can be increased 
substantially by attaching, low molecular weight PAA to Hb to form discrete Hb-PAA 
nanoparticles, as opposed to nanogels, via a general, simple, efficient and facile synthetic 
strategy (Scheme 2).  The resulting Hb-PAA nanoparticles resist deactivation by steam 
sterilization. This simple strategy may be extended to other protein-PAA conjugates and 
attaining such thermal stability is a major breakthrough for the biomedical/biomaterial 
applications that require sterilization or long term stability.
25,26
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1.3  Experimental 
1.3.1  Chemicals and Materials 
 Bovine met-hemoglobin (Hb) was purchased from MP Biomedicals (Solon, OH).  Protein 
solutions were prepared in the respective buffers used for synthesis, as indicated, and the 
concentrations determined from the Soret absorbance of Hb using extinction co-efficient 303,956 
M
-1
cm
-1
 at 407 nm.
27
 
 
1.3.2  Polyamines 
 Ethylenediamine (en), triethylenetetramine (teta), and tetraethylenepentamine (tepa) were 
purchased from Sigma (St. Louis, MO). Stock solutions of the polyamines were prepared in 
deionized water (DI) and the pH was adjusted to 7.2 with concentrated hydrochloric acid before 
the solutions were made to their final volumes.  
 
1.3.3  Protein-Polymer Conjugate Synthesis 
 The Hb-PAA conjugates were synthesized by using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), purchased from TCI America (Portland, OR), as the coupling agent by 
reported methods,
28
 with minor modifications. PAA (MW 8,000) solution 45% (w/w) was 
purchased from Sigma-Aldrich (St. Louis, MO) and diluted four-fold to a concentration of 18.6 
mM by the addition of DI.  A mixture of 500 μL of 200 mM Na2HPO4 buffer at pH 6, 7 or 8 with 
270 μL of PAA (1 mM) and 3730 μL of deionized water were added to a reaction vial, followed 
by sonication for 5 minutes. Next, 100 mmol of EDC was added to the vial while stirring.  The 
resulting PAA/EDC mixture was stirred for 5 minutes and then 500 µl of 10 µM Hb (50 nmol) 
was added and stirred for 12 h.  Specific reaction conditions for each of all the samples are 
 10 
  
summarized in tables 1 & 2.  Excess EDC, PAA and urea by-product were dialyzed 3 times with 
1000 times the sample volume with 25 kDa molecular weight cut off dialysis membrane to 
obtain pure protein-polymer conjugates.  
The product obtained from the reaction of 5000 nmol of PAA with Hb (50 nmol) at pH 7 (PAA to 
Hb mole ratio of 100:1) is designated as Hb-PAA(100)-7, while the reaction of 50,000 nmol PAA with 50 
nmol of Hb (PAA to Hb mole ratio of 1000:1) at pH 7 is labeled as Hb-PAA(1000)-7. This nomenclature 
will be used throughout the manuscript for unique identification of specific Hb-PAA nanoparticle 
samples. Each sample has been centrifuged at 12,000 RPM and filtered using 0.22 µm filter to remove 
invisible precipitates, if any. 
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Table 1.1. Optimized Reaction Conditions for the synthesis of Hb-PAA(100)-6/7/8 and Hb-
PAA(1000)-6/7/8 from Hb (10 μM, 500 μL, 50 nmol), PAA ( 270/2700 µL, 1 or 10 mM, 5 or 50 
µmol, 1:100 or 1:1000 Hb to PAA mole ratio) and EDC (100 mM, 95.8 mg, 500 μmol) in 
sodium dibasic phosphate buffer. 
 
Sample [PAA] 
(mM) 
PAA Vol 
(μL) 
Moles 
PAA 
Buffer 
pH 
Buffer 
Vol (μL) 
DI Vol 
(μL) 
Hb-PAA(100)-6 1 270 5 μmol 6 500 3730 
Hb-PAA(100)-7 1 270 5 μmol 7 500 3730 
Hb-PAA(100)-8 1 270 5 μmol 8 500 3730 
Hb-PAA(1000)-6 10 2700 50 μmol 6 500 1300 
Hb-PAA(1000)-7 10 2700 50 μmol 7 500 1300 
Hb-PAA(1000)-8 10 2700 50 μmol 8 500 1300 
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Table 1.2. Optimized Reaction Conditions for Synthesis of Polyamine Cross-linked 
Bioconjugates from Hb-PAA(1000)-8 (5 μM, 2500 μL, 25 nmol), polyamine (en [2 M], teta [1 
M] or tepa [1 M]) and EDC (100 mM, 95.8 mg, 500 μmol) in 20 mM Na2HPO4, pH 8 
 
Sample [en] 
(mM) 
Moles en [teta] 
(mM) 
Moles 
teta 
[tepa] 
(mM) 
Moles 
tepa 
Hb-PAA(1000)-8-5en 5 25 μmol - - - - 
Hb-PAA(1000)-8-10en 10 50 μmol - - - - 
Hb-PAA(1000)-8-20en 20 100 μmol - - - - 
Hb-PAA(1000)-8-40en 40 200 μmol - - - - 
Hb-PAA(1000)-8-60en 60 300 μmol - - - - 
Hb-PAA(1000)-8-5teta - - 5 25 μmol - - 
Hb-PAA(1000)-8-10teta - - 10 50 μmol - - 
Hb-PAA(1000)-8-20teta - - 20 100 μmol - - 
Hb-PAA(1000)-8-40teta - - 40 200 μmol - - 
Hb-PAA(1000)-8-60teta - - 60 300 μmol - - 
Hb-PAA(1000)-8-5tepa - - - - 5 25 μmol 
Hb-PAA(1000)-8-10tepa - - - - 10 50 μmol 
Hb-PAA(1000)-8-20tepa - - - - 20 100 μmol 
Hb-PAA(1000)-8-40tepa - - - - 40 200 μmol 
Hb-PAA(1000)-8-60tepa - - - - 60 300 μmol 
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1.3.4  Protein-Polymer Cross-Linking with Polyamines 
 Polyamines were used to crosslink the PAA chains of the above Hb-PAA nanoparticles, 
using EDC coupling chemistry.  To Hb-PAA(1000)-8 in 20 mM Na2HPO4 buffer at pH 8 (5 µM 
protein, 5 mL) was added 100 mmol of EDC and the mixture stirred for another 5 minutes before 
various volumes of polyamines have been added to gain the desired concentrations of polyamine 
(en, teta, and tepa, reaction conditions for other samples given in the ESI, Table S2).  The 
reaction mixture was further allowed to stir overnight, at room temperature. Excess EDC, PAA 
and urea byproduct were removed via dialysis with 25 kDa molecular weight cut off dialysis 
membrane. 
 
1.3.5  Agarose Gel Electrophoresis 
 Native agarose gels were prepared by dissolving molecular biology grade agarose (0.5% 
w/v) (U.S. Biological, Swampscott, MA) in a hot solution of Tris-Acetate (40 mM, pH 7.2).29  
The gel was run in a horizontal gel electrophoresis apparatus (Gibco model 200, Life 
Technologies Inc, MD) using Tris-Acetate (40 mM pH 7.2) as the running buffer. Samples were 
loaded into the gel with loading buffer (50 % v/v glycerol and 0.01% m/m bromophenol blue) 
and electrophoresis carried out for 30 minutes at 100 V at room temperature. The gel was stained 
overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue and then destained with 10% 
v/v acetic acid for an additional night. Polyamine cross-linked protein-polymer nanoparticles 
were stained by Zn(II) reverse staining procedure.30  The gel was incubated for 25 minutes in 
ZnSO4-Imidazole solution (15 mM ZnSO4:30 mM Imidazole) followed by incubation in a 10% 
(w/v) Na2CO3 solution to develop the bands.  The gel was photographed using a Molecular 
Imager Gel Doc XRS System. 
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1.3.6  Transmission Electron Microscopy 
 Transmission electron microscopy (TEM) was used to examine the morphology of Hb-
PAA conjugate, Hb and PAA physical mixture (Hb/PAA), Hb and PAA. The images were 
obtained with a Tecnai T12 instrument operating at an accelerating voltage of 120 kV. Solutions 
of Hb-PAA, Hb/PAA and PAA were diluted to 0.1 mg/ml based on PAA concentration. The Hb 
solution was diluted to 0.1 mg/ml Hb. A drop of each solution was deposited on a copper grid 
covered with Fomvar film. Excess solution was blotted away with a piece of filter paper to leave 
a thin layer of solution on the grid. The sample was left to dry in air, and then stained with 
ruthenium tetroxide for 30 minutes. Digital images were collected and presented. 
 
1.3.7  Dynamic Light Scattering 
 Nanoparticle sizes were determined by Precision Detectors (Varian Inc., Santa Clara, 
CA) CoolBatch+ dynamic light scattering (DLS) apparatus using a 5 x 5 mm square cuvette, 658 
nm excitation laser source with a 90° geometry for the excitation and monitoring optics.  
Samples were routinely filtered with a 0.2-micron filter prior to analysis to remove dust particles 
and any large aggregates.  
 
1.3.8  Spectral Measurements 
 The absorption spectra were recorded on HP 8453 spectrophotometer (Agilent 
Technologies, Santa Clara, CA).  The Hb solutions mixed in the respective buffers was 
determined from the Soret absorbance of Hb using an extinction coefficient of 303,956 M
-1
cm
-1
 
at 407 nm.  Further, the denaturation temperatures of Hb, Hb/PAA and Hb-PAA were 
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determined by measuring the thermal transition points from the plots of Soret absorbance at 407 
nm as a function of temperature.  
 
1.3.9  Circular Dichroism 
 A JASCO model J715 spectropolarimeter (Jasco Inc, Easton, MD) was used to record the 
circular dichroism (CD) spectra.  Scan rates were 50 nm/min with a step resolution of 1 nm/data 
point.  Several scans (8-16) were averaged for each sample (0.05 and 1 cm path length) and data 
plotted using Kaleidagraph 4.1.1. Samples for CD were prepared as mentioned above and signals 
have been normalized with respect to concentrations of individual samples and the pathlength. 
 
1.3.10  Enzymatic Activity Assays 
 The peroxidase-like activity of Hb was measured by following the literature method, as 
reported earlier.
31
  Product absorbance at 470 nm was monitored as a function time of after the 
addition of H2O2 (1 mM) to Hb (1 µM) and o-methoxyphenol (2.5 mM).  Lineweaver-Burk plots 
for the protein-polymer conjugates were constructed by obtaining initial reaction rates at various 
substrate concentrations and by plotting inverse initial rate vs inverse substrate concentration. 
The corresponding Michaelis-Menten parameters, the Michaelis constant (Km) and the maximum 
velocity (Vmax), were extracted from this plot
29
 as reported earlier.
31
  All peroxidase-like 
activities of steam sterilized samples were measured with 1 µM Hb, 2.5 mM guaiacol and 1 mM 
H2O2 in 20 mM Na2HPO4 buffer, pH 7.2, or 8, at room temperature using the above method. 
 
1.3.11  Differential Scanning Calorimetry 
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A Nano II differential scanning calorimeter (DSC) 6100 from Calorimetry Sciences 
Corporation (CSC, Utah) was used to perform thermal denaturation experiments.
32
  The amount 
of heat required to increase the temperature of a sample with respect to a reference (Cp) by 1 ºC 
was monitored in a series of heating and cooling scans from 20 to 120 ºC at a scan rate of 2 
ºC/min. Thermodynamic parameters (∆H, and Tm) were obtained from the DSC traces, as 
described earlier. 
 
1.3.12  Steam Sterilization 
An Amsco Century Scientific (Steris, Mentor, OH) model SI-120 isothermal sterilizer 
was used for steam sterilization.  Liquid samples containing Hb-PAA conjugates and unmodified 
proteins were steam sterilized for 40 min at 122 ˚C (17-20 psi). Samples were cooled down to 
room temperature and the peroxidase-like activity of Hb and Hb-PAA conjugates were 
measured, as described above. The initial rates were calculated using Kaleidagraph from the 
kinetic traces of absorbance vs time plots, and specific activities have been calculated. 
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1.4  Results and Discussion 
Hb-PAA covalent conjugates are synthesized by covalent linking of the carboxyl 
functions of PAA with the amino groups of the lysine side chains of Hb, under controlled 
conditions of stoichiometry, polymer concentration, polymer molecular weight, pH and reaction 
time.  Previously, we have shown that covalent linking of high molecular weight PAA (MW 
450,000) to Hb resulted in the formation of protein-polymer nanogels which did not retain 
activity after steam sterilization.
17
  Here, we lowered the PAA molecular weight and its 
concentration to suppress network formation, and increased the mole ratio of polymer to protein 
to produce discrete Hb-PAA nanoparticles, which indicated high resistance to thermal 
deactivation.  
 
1.4.1  Synthesis of Hb-PAA Nanoparticles 
Proteins, in general, are polyfunctional molecules with large numbers of amine and 
carboxyl groups on them. The amino groups of the lysine side chans of proteins have been 
successfully coupled with a large number of substrates consisting of carboxyl groups, via the 
standard carbodiimide chemistry.
33
  A similar strategy was followed here (Scheme 2). Covalent 
attachment of a large excess of PAA (MW 8000, 100 or 1000-fold molar excess) to the lysine 
side chains of Hb was carried out by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) at 
pH 6, 7 or 8, in 20 mM Na2HPO4 buffer (ESI, Table S1). All the conjugates reported here were 
completely soluble at all times, and there have been no precipitates or gel formation.  Most 
mammalian Hb molecules have ~44 lysine residues, and a large number of them can potentially 
react with the activated carboxyl groups of PAA.  The Hb/PAA/EDC reaction mixture was 
allowed to react for 12 h and dialyzed to remove the unreacted PAA, EDC or urea by-products.  
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All samples reported here are completely water-soluble and there have been no precipitates 
under our reaction conditions.  Progress of the crosslinking reaction was followed by agarose gel 
electrophoresis, described below. 
 
1.4.2  Agarose Gel Electrophoresis 
The covalent attachment of anionic PAA to Hb is expected to give rise to negatively 
charged Hb-PAA conjugates, and this conversion of positively charged Hb to negatively charged 
conjugate is expected to increase its electrophoretic mobility toward the positive electrode.  In 
contrast, if the synthesis resulted in the formation of macroscopic protein-polymer macrogels, the 
gels would not migrate through the narrow pores due to their large size, when compared to the 
gel pores (~450 nm).  As anticipated, the Hb-PAA(100) conjugates (100-fold excess PAA per 
Hb, lanes 4-6, Fig. 1) moved towards positive electrode, while Hb, Hb/PAA physical mixture, or 
Hb/EDC mixture (lanes 1-3, respectively) migrated towards the negative electrode.  Migration 
reversal is not due to physical binding of PAA to Hb, as the mixture (lane 2) migrated toward the 
negative elecgtrode but not the positive electrode.  The presence of a new band in lanes 4-6 and 
the absence of the Hb band, indicated complete conversion of Hb to the corresponding Hb-PAA 
conjugate. In contrast, the Hb-PAA nanogels produced from the conjugation of high molecular 
weight PAA (MW 450,000) with Hb, moved as streaks, under the same conditions of 
electrophoresis.
17a 
 Thus, the covalent linking of the anionic polymer to Hb to form discrete 
particles is clearly demonstrated. 
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Positive Electrode 
 
Negative Electrode 
         Lane    1           2    3          4    5    6 
Figure 1.1.  Agarose gel of Hb (lane 1), Hb/PAA physical mixture (lane 2), Hb/EDC mixture 
(lane 3) and Hb-PAA(100) nanoparticles synthesized at pH 6, 7 and 8 (lanes 4-6, respectively) 
spotted at the center of the gel (0.5% agarose, 40 mM Tris acetate, pH 6.5). The Hb, Hb/PAA 
physical mixture and Hb/EDC mixture migrated towards the negative electrode, while all the 
three Hb-PAA(100) covalent conjugates moved towards the positive electrode.  These lanes did 
not show any unreacted Hb. 
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We also prepared Hb-PAA(1000) samples at pH 6, 7, and 8,  where there has been 1000-
fold molar excess of the polymer, and compared the mobilities of these samples with those of 
Hb-PAA(100) samples (Figure 2). While the Hb-PAA(100) samples indicated tight bands (lanes 
2-4), the Hb-PAA(1000) samples (lanes 5-7, respectively) had more diffuse bands due to higher 
concentrations of PAA.  These lanes also did not indicate free Hb (lane 1) and both reaction 
conditions resulted in the complete conjugation of Hb with the polymer, and there has been no 
visible precipitation under any of the reaction conditions reported here.   
Electrophoretic mobilities of all the Hb-PAA conjugates (both 1:100 and 1:1000 mole 
ratio samples, prepared under three different pH conditions) indicated a measure of the charge 
and size.  The average pore size of agarose gel used in Figure 1 & S1 (0.5% gel) is around 450 
nm,
 34
 and all the Hb-PAA conjugates moved readily through these pores.  Therefore, the 
conjugates are likely to be much smaller than 450 nm. Additionally, there is no formation of 
macroscopically crosslinked gels, which would have indicated streaks of bands or precipitation 
in the wells.
17a
  This conclusion is consistent with the observed high solubility of the conjugates 
in the reaction mixture and the low overlap concentration of low molecular weight of PAA (MW 
8,000) used in the current studies. The agorose gel data confirm the clean ligation of Hb to PAA 
with particle sizes well below 450 nm.
35
  All conjugates reported here are completely water 
soluble and there have been no precipitations under any of these conditions. 
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               Lane #   1      2      3      4       5       6      7 
Figure 1.2.  Agarose gel of Hb (lane 1), Hb-PAA(100) samples synthesized at pH 6, 7, 
and 8 (lanes (104, respectively) and Hb-PAA(1000) samples synthesized  pH 6, 7, and 8, 
(lanes 5-7, respectively) spotted at the center of the gel (0.5% agarose, 40 mM Tris 
acetate, pH 7). Hb, migrated towards the negative electrode, while all the three Hb-
PAA(100) covalent conjugates moved towards the positive electrode.  These lanes did 
not show any unreacted Hb. 
Positive Electrode 
Negative Electrode 
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1.4.3  Elemental Analysis 
 Covalent conjugation of carbon rich PAA polymer to Hb is expected to increase the C:N 
ratio, and from this ratio, one can assess the amount of polymer bound per protein molecule.  For 
example, the C:N ratio of 6.34 was measured for the Hb-PAA(1000)-8 which increased from 
3.51 for the untreated Hb.  Since the nanoparticles were extensively dialyzed to remove 
unreacted PAA, the increase in C:N ratio is indicative of increase in carbon content (PAA) of the 
conjugate.  From this ratio we deduce that on average nearly 7 PAA polymer chains were 
attached for every Hb in Hb-PAA(1000)-8, giving a Hb:PAA stoichiometry of 1:7.  Since 
molecular weight of PAA is 8000, that of Hb is 64,500, and seven of these chains are attached to 
one Hb molecule, the average mass ratio of protein to polymer is nearly (64,500):(7x8,000) or 
~1:0.9, or approximately equimass ratio.  Thus, each protein molecule is surrounded by several 
low molecular weight polymer chains, and even at 1000-fold higher concentration of PAA only a 
few chains are attached to the protein.  
 
1.4.4  TEM and DLS 
 The Hb-PAA samples were visualized by TEM to determine their morphology, size, 
shape and phase separation characteristics. In general, TEM micrographs indicated spherical 
particles and we did not see macrogels or highly crosslinked products (Figure 2). Hb-PAA(100) 
synthesized at pH 7, for example, (Figure 2b) indicated spherical spots with a dark core and very 
light corona (inset). 
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Figure 1.3.  TEM images of Hb-PAA(100) and Hb-PAA(1000) samples synthesized at pH 6, 7 
or 8 after ruthenium oxide staining: a) Hb-PAA(100)-6, b) Hb-PAA(100)-7, c) Hb-PAA(100)-8, 
d) Hb-PAA(1000)-6, e) Hb-PAA(1000)-7 and f) Hb-PAA(1000)-8. In some micrographs, the 
dark spots at the centers (insets) are clearly surrounded by a very light corona. 
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The TEMs of the Hb-PAA(100) samples synthesized at 6, 7 and 8, are compared in 
Figure 2(a-c) and none of these indicated nanogels or macroscopically crosslinked gels.  The 
insets in these panels are expanded views of randomly chosen particles to illustrate their contours 
better, and the average sizes of the Hb-PAA(100) particles synthesized at pHs 6, 7, and 8 were 
~250, ~125 and ~100 nm (Figure 2a-c), respectively. The particle size decreased, percptibly, 
with increase in pH, at Hb:PAA concentration ratio of 1:100.  This decrease in size could be due 
to increased charge repulsion between the PAA and Hb chains, as the pH is increased and fewer 
molecules are attached at higher pH.   
Next, we examined the influence of PAA concentration on the particle formation and the 
TEM micrographs of Hb-PAA(1000) samples prepared with a protein to polymer ratio of 1:1000 
also indicated nanoparticles (Figure 2e).  These are also nearly spherical, with a dark core and a 
very light corona, in some cases, and they also did not indicate the formation of any macroscopic 
gels.  These are compared with those synthesized at pH 6 and 8 (Figure 2d-f) which also showed 
spherical nanoscopic species, and none of them indicated nano- or macrogels. The Hb-
PAA(1000) samples synthesized at pH 6, 7, and 8 had average sizes ~80, ~90 and ~100 nm, 
respectively, and these are smaller than those obtained at lower stoichiometries of Hb to PAA.  
Higher polymer concentration (higher stochiometry) decreased the particle size, and this could 
be due to the greater distribution of Hb molecules among a larger number of PAA chains, 
resulting in smaller particle formation. 
The sizes of the 1000:1 samples increased slightly with increase in pH which is opposite 
to what was noted with the 100:1 samples, where the size decreased with increase in pH. Thus, 
not only the pH but also the polymer concentration influenced the particle size to a measurable 
extent, while the shape and morphology appears to be nearly independent of these factors.  
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Lower pH and higher PAA concentration resulted in the smallest particles.  Thus, the particle 
size can be tuned from about 250 nm to around 80 nm, in a predictable manner, depending on the 
reaction conditions. 
The formation and size of the Hb-PAA nanoparticles determined from TEM are also 
corroborated by dynamic light scattering (DLS) data (Figure 3), where the trends in size with pH 
and polymer concentration are similar to those obtained from TEM micrographs.  The conjugates 
synthesized at pH 6.0 show major distribution, around 150 nm, while the conjugates synthesized 
at pH 7.0 and 8.0 show the major size distribution around 145 and 114 nm, respectively. 
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Figure 1.4.  Dynamic light scattering plots for Hb-PAA(100) and Hb-PAA(1000) conjugates 
synthesized at pH 6, 7 and 8, respectively.  The conjugates synthesized at pH 6.0 show major 
distribution, around 150 nm, while the conjugates synthesized at pH 7.0 and 8.0 show the major 
size distribution around 145 and 114 nm, respectively.  All samples were in 20 mM Na2HPO4 
buffer. 
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1.4.5  Hemoglobin Structure in Hb-PAA Conjugates 
Native structure of the encapsulted protein is critical for the retention of its biological 
activity, and we used circular dichroism (CD) spectroscopy to assess Hb structure before and 
after conjugation to PAA.  The CD spectra of the Hb-PAA nanoparticles in the far-UV region 
(Figure 4a) are similar to that of Hb,
36
 and these indicated significant retention of its native-like 
secondary structure upon conjugation with PAA.   These peak positions, intensities and ratio of 
the intensities of 222/209 nm peaks are compared in Table 1.  In conclusion, the UV CD data 
confirm that the protein secondary structure is not adversely effected by the conjugation reaction. 
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a  b  
Figure 1.5.  (a) Far UV CD of Hb, and Hb-PAA(100) conjugates synthesized at pH 6 (red), 
7 (green) and 8 (blue) when compared to that of Hb (black); (b) Soret CD of the Hb-
PAA(100) samples with the same color code, as the left panel. All spectra were normalized 
to obtain molar rotation per unit path length. 
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The Soret absorption band of Hb also gives rise to the corresponding CD and it is a 
sensitive signature of the structural changes at the heme binding pocket.  Soret CD served as 
another means to interrogate the influence of conjugation on protein structure.  The Soret CD of 
the Hb-PAA(100) samples synthesized at pH 6, 7 and 8 are compared with that of Hb (Figure 
4b), and these indicated some loss in intensity after conjugation, but the peak positions of the 
nanoparticles matched with that of Hb.  The Soret CD spectra suggest that the heme binding 
pocket has undergone some distortion, even though the secondary structure of Hb remained 
mostly intact.  These CD data are summarized in Table 3, for convenience, and these clearly 
show significant retention of the secondary structure, but the loss in Soret intensity of some 
derivatives was of concern, and hence, we tested if these changes adversely influenced the 
peroxidase-like activity of Hb-PAA nanoparticles, as discussed below. 
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Table 1.3.  Far UV and Soret CD intensities (mdeg/µM.cm) of Hb-PAA(100) conjugates   
 
 
 222 nm 209 nm 222/209 nm 409 nm 
Hb -80 -74 1. 07 2. 17 
Hb/PAA -92 -89 1. 03 2. 05 
Hb-PAA(100)-6 -93 -88 1. 06 1. 13 
Hb-PAA(100)-7 -91 -88 1. 03 1. 93 
Hb-PAA(100)-8 -86 -91 1. 00 1. 56 
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1.4.6  Peroxidase-like Enzymatic Activities of Hb-PAA 
Hb does not function as an enzyme in biological systems but its peroxidase-like activity 
has long been known.
37,38
  Catalytic activity of Hb-PAA nanoparticles was monitored by the 
reaction of guaiacol (substrate) with hydrogen peroxide (oxidant), and formation of the colored 
product has been monitored by its absorption at 470 nm, as a function of time (Figure 4).  For 
example, the product formation catalyzed by Hb-PAA(100)-6 (Figure 4a, green curve) is nearly 
comparable to that of Hb (black curve), there has been no reaction in the absence of hydrogen 
peroxide (red curve), and PAA did not catalyze the reaction (data not shown).  A mixture of Hb 
and PAA (black dashed curve) indicated activites that are lower than that of the corresponding 
Hb-PAA conjugate. 
Similarly, the peroxidase activity of Hb-PAA(1000)-7 is shown in Supplementary 
Materials S4, and the activities are comparable to that of Hb or the physical mixture of Hb/PAA.  
These data are consistent with the conclusion that PAA did not adversely influence peroxidase 
activity of Hb-PAA nanoparticles. 
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a   b  
c  
Figure 1.6. (a) The peroxidase-like activities of Hb-PAA(100)-6 (green curve), Hb, (black 
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen 
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4 
buffer, pH 7.2). (b) The peroxidase-like activities of Hb-PAA(1000)-7 (green curve), Hb, (black 
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen 
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4 
buffer, pH 7.2). (c) Comparison of the specific activities of Hb-PAA nanoparticles with that of 
Hb and physical mixtures, all measured at room temperature, 1 µM protein, 2.5 mM guaiacol and 
1 mM H2O2 in 20 mM Na2HPO4 buffer, pH 7.2.  
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The initial rates from the kinetic traces of all the six Hb-PAA nanoparticle samples were 
measured and compared with those of Hb and Hb/PAA physical mixtures (Figure 5c).  The 
conjugates showed significant activity, and only in the case of Hb-PAA(100)-8, substantial 
reduction has been noted (~40% loss), the remaining five samples had specific activities close to 
that of Hb (Table 5). Some improvements may have been noted in some cases but these are well 
within the experimental errors indicated.  While the Hb/PAA(100) physical mixture was nearly 
as active as Hb, the Hb/PAA(1000) physical mixture was measurably less active and this could 
be due to increased viscosity of the solution due to the higher PAA concentration in the mixture.  
The majority of Hb-PAA nanoparticles, however, retained most of their peroxidase-like 
activities.  
Initial reaction rates from the kinetic data were obtained at a series of substrate 
concentrations and they have been  used to construct Michaelis-Menton plots for the extraction 
of the corresponding enzymatic parameters, Michaelis constant (Km) and the maximum velocity 
(Vmax).
29
 The plot of inverse of the initial rate as a function of the inverse of the substrate 
concentration indicated linear plots for Hb-PAA(100)-6 and Hb-PAA(100)-7 (Figure 6). 
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Figure 1.7.  Lineweaver-Burk plots for the peroxidase-like activities of Hb-PAA(100)-6 
(black dots), Hb-PAA(100)-7 (red dots).  Lines are best fits to the data using the Lineweaver-
Burk equation.  All reactions were carried out in the presence of 1 µM Hb-PAA(100)-6 or 
Hb-PAA(100)-7, increasing guaiacol concentration and 1 mM H2O2 in 20 mM Na2HPO4 
buffer, pH 7.2, room temperature. 
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Table 1.4.  Specific activities (x10
-3 
µM/mg) of Hb-PAA nanoparticles measured at 25 ˚C, 20 
mM phosphate buffer, pH 7.2. 
 
Sample Specific activity (x10
-3 
µM/mg) 
Hb 2. 5  0.3 
Hb/PAA(100) 2. 3  0.07 
Hb-PAA(100)- 6 2. 4  0.5 
Hb-PAA(100)- 7 2. 0  0.2 
Hb-PAA(100)- 8 1. 4  0.07 
Hb/PAA(1000) 2. 0  0.07 
Hb-PAA(1000)- 6 2. 7  0.4 
Hb-PAA(1000)- 7 2. 6  0.07 
Hb-PAA(1000)- 8 2. 4  0.1 
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Linear fits to these data (Figure 6) using the Michaelis-Menton model indicated Vmax of 
0.0028, 0.0025 and 0.0026 mM/s and Km of 1.25, 0.375 and 0.50 mM, for Hb-PAA(100)-6, Hb-
PAA(100)-7 and Hb,
39
 respectively. under similar conditions of buffer, ionic strength, 
temperature and pH.  The maximum velocities observed with all the three samples, for example, 
are similar, and polymer conjugation did not alter this parameter to a significant extent.  While 
the Km of Hb-PAA(100)-6 is three times larger than that of Hb, the Km of Hb-PAA(100)-7 
matched well with that of Hb.  Enhanced Km of Hb-PAA(100)-6 is indicative of a decrease in its 
affinity for the substrate, and this observation is intriguing but it also coincides with the 
substantial loss of its Soret CD band.  Therefore, in this case, the heme-pocket in the globin is 
distorted enough to cause substantial reduction of the binding of the substrate at the active site 
but not its catalytic efficiency.  Overall, the catalytic parameters found for Hb-PAA 
nanoparticles are consistent with the notion that formation of the covalently conjugated 
nanoparticles did not substantially alter Hb native-like structure or its peroxidase-like activities. 
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1.4.7  Melt Curves and DSC Studies 
Encouraged by the retention of secondary structure and biocatalytic activities of the Hb-
PAA nanoparticles, we next assessed their thermal stability by recording Soret absorbance as a 
function of temperature (melt curves) as well as by differential scanning calorimetry (DSC).  
While the melt curves provide a quick measure of thermal stability, reversibility and precipittion 
of the sample during or after denaturation, the DSC
40
 provides a direct quantitative measure of 
the thermodynamic parameters of thermal denaturation.
41
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a  b  
Figure 1.8.  (a) Melt curves of Hb, Hb/PAA physical mixture, and Hb-PAA(100)-7 recorded by 
monitoring heme absorption at 410 nm as a function of temperature. Improved stability of the 
conjugate is indicated by the shift of its melt curve to higher temperatures; (b) DSC thermograms 
(molar heat capacity plots) of Hb-PAA(100)-7 (green curve), Hb (black curve), and the Hb/PAA 
physical mixture (dotted line) as a function of temperature. 
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On one hand, a plot of the ratio of the Soret absorbance of the sample at 407 nm (A) to 
initial absorbance of the sample (Ao) as a function of temperature (Figure 7a), indicated a sharp 
increase flollowed by decrease with a peak around 65 ˚C for Hb (black curve), and this is 
consistent with the denaturation of Hb followed by its precipitation from solution, around this 
temperature.
42
  On the other hand, the melt curve for Hb-PAA(100)-7 (Figure 7a, green line), 
under the same conditions of buffer, pH and ionic strength, indicated the beginning of a change 
around 60 ˚C, which continued upto 100 ˚C but no precipitation has been noted. The physical 
mixture of Hb and PAA (black dotted line) indicated some stabilization followed by denaturation 
but eventually precipitated.  Thus, Hb-PAA(100)-7 indicated improved thermal stability when 
compared to that of Hb or the corresponding Hb/PAA physical mixture.   The melt curves of 
other Hb-PAA conjugates also indicated improved stability when compared to that of Hb, no 
precipitation, and the Soret absorption band recovered upon cooling the samples to room 
temperature.  These details are discussed latter. 
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Table 1.5.  Thermodynamic parameters for the denaturation of Hb-PAA nanoparticles 
 Hb Hb/PAA Hb-PAA(100)-6 Hb-PAA(100)-7 Hb-PAA(100)-8 
Td/˚C 68±0.2 68±0.5 61±3.0 77±3.0 65±1.2 
∆H/kcal/mol 135±5 145±10 310±40 540±35 130±20 
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To quantify the thermodynamic parameters of protein denaturation, the DSC curves of 
Hb-PAA(100)-7, Hb and Hb/PAA physical mixture were recorded and the denaturation 
temperatures (Td) have been determined (Figure 6b). The DSC profile of Hb-PAA(100)-7 (green 
curve), for example, indicated a small peak around 77 ˚C, and then a much larger transition near 
100 ˚C. The first, smaller peak is slightly shifted to higher temperature when compared to that of 
Hb (black curve, Td of 68 ˚C).
42
  The DSC profile of the Hb/PAA physical mixture (balck dotted 
curve) indicated an endothermic transition larger than that of Hb, with a Td of 63 ˚C, below that 
of Hb. PAA itself (thin black line) did not indicate any detectable transition in this temperature 
range, and hence, the nanoparticles indicated much greater stability (two separate transitions) 
when compared to that of Hb or the correspnding physical mixture. Such high thermal stability is 
unusual for most proteins.
43
 
The denaturation enthalpies (∆H) were estimated from the DSC curves, and these are 
compared in Table 2. The ∆H for the denaturation of the nanoparticles  ranged from 130 to 540 
kcal/mol, and enthalpy changes of Hb-PAA(100)-6 and Hb-PAA(100)-7 are significantly higher 
than those of Hb (135 kcal/mol) as well as Hb/PAA physical mixture (145 kcal/mol). Hb-
PAA(100)-8 had denaturation enthalpy and peak transition temperatures similar to that of Hb.  
The improved thermal stability of Hb-PAA(100)-7 (Td shifted to higher temperature, another 
transition at higher temperature as well as higher enthalpy of denaturation) is clearly 
demonstrated. Thus, the thermal stabilities are either comparable to that of Hb or higher, and 
hence, we decided to examine the extent of reversibility of the thermal denaturation of the Hb-
PAA conjugates.  If the denaturation is fairly reversible, then the nanoparticles are of high 
promise for steam sterilization studies, and we used steam sterilization as a benchmark of 
thermal stability. 
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1.4.8 Reversibility of Thermal Denaturation 
To test the reversibility of the thermal denaturation of the Hb-PAA nanoparticles, these 
were heated to 90 ˚C followed by cooling to room temperature for 15 minutes, and the CD 
spectra of the samples have been recorded before and after heat treatment. A comparison of the 
CD spectra of Hb-PAA(100)-7 before and after 90 ˚C treatment are compared to those of the Hb 
treated in a similar manner (Figure 7). The Hb-PAA(100)-7 sample, which showed the best 
thermal stability among the three samples described in the DSC studies, indicated extensive 
retention of UV CD after the 90 ˚C heat treatment (Figure 8),  The CD spectrum of the sample 
after heating (red dotted curve) indicated the same minima and maxima peak positions as that of 
the sample before heating (red curve).  However, small decreases in the intensities of the heat 
treated sample is clearly evident, and these suggest that the thermal denaturaiton is mostly 
reversible, but not 100%. 
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Figure 1.9.  Far UV CD of Hb-PAA(100)-7 (red thick line) and Hb (black thin line) before 
heating is compared with the corresponding spectra obtained after heating the samples to 90 
˚C for 15 minutes, followed by cooling to room temperature for 15 min (red dashed, and 
black dashed lines, respectively). 
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In contrast, the CD spectra of Hb before (black solid curve) and after 90 ˚C heat 
treatment (black dashed curve) show that the peak intensities decreased substantially, and its 
thermal denaturation is essentially irreversible, under the same conditions of pH, buffer and ionic 
strength.  Near-complete reversibility of thermal denaturation of the Hb-PAA(100)-7, however, 
is clearly demonstrated above, and the soft, hydrophilic polymer might facilitate refolding, upon 
cooling to room temperature.  Improved resistance to heat deactivation and facilitated recovery 
of the native-like structure after heating, are in support of the initial hypothesis, and next, we 
examined the resistance to steam sterilziation as a bench mark of protein thermal stability. 
 
1.4.9  Stability towards steam sterilization 
Improved resistance of Hb-PAA(100)-7 toward heat and near-complete reversibility of 
denaturation indicated that the Hb-PAA nanoparticles are potentially promising candidates to test their 
ability to resist deactivation by steam sterilization.  We examined the peroxidase-like activities of Hb-
PAA samples after they have been subjected to steam sterilization conditions (122 ˚C, 40 minutes, 17-20 
psi) and  cooled back to room temperature.  If the samples retained their activities after steam 
sterilization, it would be a major breakthrough in improving Hb stability. 
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a 
 
b 
 
Figure 1.10.  Effect of steam sterilization (122 ˚C, 40 minutes, 17-20 psi) on the relative 
activities of: (a) Hb-PAA nanoparticles compared with those of Hb, Hb/PAA physical 
mixtures which are also treated similarly, and (b) polyamine crosslinked Hb-PAA(1000)-8 
nanoparticles compared with that of Hb, before and after steam sterilization. All 
measurements were in phosphate buffer, pH 7.2, at room temperature. 
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The peroxidase-like activities of the steam sterilized samples are measured at room 
temperature, and the extent of recovery of activity or the ratio of the initial rate before heating to 
initial rate after heating of each sample is shown in Figue 9a.  If the activity is not affected by 
heating, this ratio will be 1, while the actual value shows the per cent activity retention, so that 
all samples can be compared with a single measure.   
Essentially all Hb-PAA(100) samples, retained their activities by 75-85% and this is 
remarkable. Hb-PAA(100)-6, for example, retained nearly 80% of its activity after steam 
sterilization.  In contrast, Hb lost almost 80% of its activity after sterilization, retained only 
~20% of its original activity, and the Hb-PAA(100) nanoparticles showed extensive resistance to 
deactivation by steam sterilization.  Hb-PAA(1000)-7 and Hb-PAA(1000)-8 also retained 
appreciable activities, but much less than their Hb-PAA(100) counterparts.  Extensive activity 
retention is a surprise, as the Hb-PAA nanogels prepared from high molecular weight PAA 
(450,000) did not retain their activities after steam sterilization.
17
  Thus, the polymer molecular 
weight played a major role in the resistance to thermal deactivation. Note that Hb/PAA physical 
mixtures also resisted thermal deactivation to a substantial extent and this clearly shows the role 
of the polymer in assisting the refolding of the denatured Hb or the prevention of the aggregation 
of denatured Hb molecules.  The advantage of the covalent linking approach of the current Hb-
PAA nanoparticles is that these samples are discrete and they will not be subjected to leaching of 
the polymer from the protein or when diluted for practical applications. 
 
1.4.10  Effect of Cross-Linking with Polyamines 
 Since Hb-PAA(1000)-8 retained only about half of its activity, we decided to examine if 
crosslinking of the COOH groups of the PAA chains with polyamines would improve their 
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resistance to thermal deactivation. The crosslinking could stiffen the polymer chain and might 
enhance protein stability or improve the reversibility of denaturation.  The Hb-PAA(1000)-8 
samples, accordingly, were crosslinked with polyamines, en, teta or tepa using EDC chemistry 
(Scheme 2), purified by dialysis, and their purity confirmed by agarose gel electrophoressis 
(Figure 10).  Due to the high PAA content of these samples, their bands do not stain properly 
with Coomassie Blue, and we used Zn(II)-imidazole reverse staining to locate the bands in the 
gel.  These amine-crosslinked samples also indicated discrete, negatively charged bands where 
the extent of negative charge inversely varied with the extent of amine-adduction.  All samples 
were completely soluble under these conditions, and no precipitation or macroscopic networks 
are formed. Reaction with the polydentate amines reduced the net charge on the particles, as seen 
in the agarose gels, but the reaction conditions were adjusted such that amines did not crosslink 
different particles, that is intraparticle crosslinking is achieved over interparticle crosslinking. 
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Positive Electrode 
 
Negative Electrode 
 
   Lane #       1     2      3      4       5      6   
EDC           -     +      +      +       +      + 
teta (mM)   -      -     60    40      20    10 
 
Figure 1.11.  Agarose gel (0.5%) of Hb (lane 1), Hb-PAA(1000) (lane 2), and Hb-PAA(1000)-
teta (lanes 3-6) synthesized in phosphate buffer, pH 8.  The samples were spotted at the bottom 
of the gel (running buffer, 40 mM Tris acetate pH 7.2).  While Hb moved as a streak (lane 1, 
faint band), Hb-PAA(1000)-8 (lane 2) and Hb-PAA(1000)-teta (lanes 3-6, crosslinked with 60, 
40, 20 and 10 mM teta, respectively) showed single bands. Hb-PAA(1000)-teta crosslinked 
nanoparticles moved lesser toward the positive electrode than Hb-PAA(1000)-8 due to 
neutralization of the negative charge by the reaction with the amine. 
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We tested stabilities and reversibility of the thermal denaturation of these amine-
conjugated Hb-PAA nanoparticles (Figure 11).  Absorbance spectra of Hb-PAA(1000)-8-
polyamine conjugates before heat denaturation at room temperature (blue curve), during 
denaturation at 90 ˚C (red curve) and after cooling back to room temperature (green curve), are 
recorded and analyzed.  For example, the Hb-PAAA(1000)-20teta sample indicated that its Soret 
band shifted from 410 to 395 nm on heating to 90 ˚C, and the Soret band shifted back to 410 nm 
upon cooling the sample back to room temperature.  The blue shift of the Soret band at 90˚C 
clearly indicates the denaturation of the protein structure around the heme binding pocket, and its 
recovery back to 410 nm upon cooling supports the notion that the protein structure is recovered 
substantially.  All three corsslinked samples (Hb-PAA(1000)-teta, Hb-PAA(1000)-tepa and Hb-
PAA(1000)-en) indicated similar, reversible thermal denaturation, under these conditions.  The 
thermal denaturation of the entrapped Hb in the conjugates, is therefore, mostly reversible.  This 
conclusion is supported by the fact that these samples also recovered their peroxidase-like 
activity to a significant extent, after steam sterilization, described earlier.  In contrast to the 
reversible denaturation of these amine conjugates, Hb underwent near-complete irreversible 
thermal denaturation, under the same conditions. 
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a  b  
c  
Figure 1.12 (a-c). Absorbance spectra of Hb-PAA(1000)-8-polyamine conjugates before heat 
denaturation at room temperature (blue curve), during denaturation at 90 ˚C (red curve) and after 
cooling back to room temperature (green curve), panels as labeled.  Thermal denaturation clearly 
shifted the Soret band to higher temperatures and upon cooling most of the Soret band intensity 
and position are recovered, which suggests a high degree of reversibility of the thermal 
denaturation of these samples.  In contrast, Hb underwent near complete irreversible thermal 
denaturation, under the same conditions. 
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These amine-modified Hb-PAA(1000)-8 samples were then evaluated for the retention of 
their peroxidase-like activity after steam sterilization.  Percent activities of the samples after 
steam sterilization with respect to that of Hb before steam sterilization are shown in Figure 8b as 
a bar graph.  All the crosslinked samples retained greater activities than Hb, and the activity 
retention with respect to Hb-PAA(1000)-8 improved initially, with the concentration of amine 
used for crosslinking, and as the amine concentration used for crosslinking increased the 
activities after steam sterilization decreased.  Some improvement over Hb-PAA(1000)-8 was 
noted in several cases and overall, the crosslinking had substantial improvement in thermal 
stability or reversibility of the denaturation.  In total, we tested 30 distinct samples or mixtures, 
and most of them except Hb, indicated substantial retention of activity after steam sterilization.  
 
1.5 Conclusions 
Covalent conjugation of suitable polymers with appropriate proteins provides exciting 
new opportunities in materials chemistry, but only a limited progress has been made due to the 
wide spread use of very few polymers such as PEG carrying a very limited number of functional 
groups.  Here, we demonstrate a simple, modular approach, where the covalent conjugation of a 
water-soluble, multifunctional polymer, PAA, to lysine residues of a generic protein such as Hb 
can be controlled to produce Hb-PAA nanoparticles with controlled size, high solubility, 
improved thermal stability and near-reversible thermal denaturation.  The conjugates are 
endowed with the biological activities of the protein with unique, novel attributes.  
Based on the TEM/DLS data, and gel electrophoresis, we suggest that discrete 
nanoparticles are formed, and covalent linking allows the co-habitation of the protein and the 
polymer phases within the same particles. Surprisingly, the Hb-PAA nanoparticles indicated 
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considerable retention of the elegant hierarchical 3D structure of Hb, its peroxidase-like activity 
and fairly narrow size distribution for a major population of the particles.  TEM data strongly 
suggest that the conjugates are primarily made of protein-PAA nanoparticles, not gels.  The 
physical characteristics of the nanoparticles such as size, structure retention and stability are 
influenced by the composition of the conjugate as well as the reaction conditions such as pH and 
stoichiometries.  
One exciting observation is that all the Hb-PAA nanoparticles tested here, retained their 
biological activities after steam sterilization, and this is highly unusual.  Most of them retained 
substantial activities while Hb lost most of its activity under these conditions.  Steam sterilization 
has been known to deactivate proteins, and it is a stumbling block in the development of protein 
therapeutics and protein-based materials for biomedical applications. Our earlier study on Hb-
PAA conjugates which used higher molecular weight PAA (MW 450,000) did not indicate 
resistance to thermal deactivation.  Therefore, the current results demonstrate dependence on the 
molecular weight of PAA as well as the high mole ratio of the protein to polymer of the 
nanoparticles.  Excess PAA reduced the extent of resistance to thermal deactivtion while 
crosslinking with polyamines improved the resistance only marginally.  Overall, several 
examples of Hb-PAA are shown here, which resist thermal deactivation well and set new 
standards for the thermal stabilities of proteins.  Our approach may provide new opportunities for 
the design of novel protein-polymer conjugates, carefully tailored, for a variety of applications 
where sterilized protein-based products are essential. 
We speculate that several unique features of these nanoassemblies are responsible for the 
observed retention of activity after steam sterilization.  One major factor, among them, is that the 
polymer assists the solubilization of the denatured protein and the individual nanoparticles are 
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kept apart from agglomeration and precipitation by the anionic polymer, so that they refold to the 
active form on cooling. Shielding of the protein from the external microenvironment by the 
polymer could enhance the intrinsic stability of the protein. There could be a kinetic factor for 
the slow denaturation of the protein or partial retention of the structure after denaturation, and 
when these factors are combined in a synergistic manner, the overall result is increased 
resistance to thermal deactivation.  These novel Hb-PAA nanoparticles provide a major 
breakthrough in the preparation of bioactive hybrid nanomaterials, which can be sterilized, 
without deactivation, for biomedical and bionsensing applications. 
Overall, Hb-PAA nanoparticles reported here are highly resistant to deactivation by 
steam sterilization, and these are welcome changes for applications in biocatalysis and 
biomaterials. These findings are significant because most proteins lose their biological activities 
when they are subjected to steam sterilization, while Hb-PAA nanomaterials retained most of 
their activity. Additionally, the protein hierarchical structure and activity in nanoparticles is 
retained to a large extent.  High thermal stability of the hybrid materials, unlike the poor thermal 
stability of most proteins, is unique, novel and extremely useful for applications that require 
sterile products. These pioneering results might provide a new paradigm for the use of protein-
polymer materials in biosensors, protein therapeutics, tissue engineering scaffolds and implants.  
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Chapter 2 
A General Approach Towards Ultra-Stable Protein-Polymer 
Bioconjugates   
 59 
  
2.1  Abstract 
Proteins and enzymes are naturally occuring polymeric biological macromolecules with 
well-defined hierarchial structures and highly specific biological activities, however, they are 
very sensitive to their environment. Environmental stimuli such as pH, temperature, bacterial 
degradation and organic solvents can readily deanture an enzyme
1
. The limitations of the 
enzymes can be overcome when conjuagted to suitable polymers via synthetic approaches
2
. Here 
we report the synthesis of a small library of protein-polymer conjugates using a facile, self-
assembled chemical method we have previously published
3
. Here we have produced protein-
polymer conjugates from covalent linking of low molecular weight poly(acrylic acid) (PAA, 
MW 8,000) to various proteins and enzyme under different experimental conditions to form 
discrete nanoparticles. The bioconjugates retained significant biological activities when 
compared to their unmodified counterparts and showed no nanogel network formation. 
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2.2  Introduction 
 Proteins and enzymes are naturally occuring polymeric biological macromolecules with 
well-defined hierarchial structures and highly specific biological activities. Enzymes can 
accelerate chemical reactions by orders of magnitude with very high selectivity, under ideal 
conditions. However, proteins are generally not suited to function as biomaterials due to their 
limitations and sensitivity to environmental stimuli such as pH, temperature, bacterial 
degradation and organic solvents
1
. The limitations of the enzymes can be overcome when 
conjuagted to suitable polymers via synthetic approaches
2
. The combination of proteins and 
polymers can lead to new structures and the design of unique biomaterials that can enhance the 
properties of both the protein and the polymer for specific applications
3
. Protein-polymer 
conjugates can be synthesized by site-specific conjugation or random conjugation
4
. Usually this 
conjugation is through a covalent link which the functional groups of the polymer are bound to 
the surface groups of the protein. Hybrid bioconjugates can potentially be used for applications 
in biosensing, biocatalysis or biomedical applications if engineered appropriately
5,6
. 
 By wrapping the proteins herein with a soft, hydrophilic, flexible polymer such as the low 
molecular weight poly(acrylic acid) (PAA, MW 8000), the stabilities of the proteins can be 
improved. Here, the synthesis of a small library of protein-polymer bioconjugates using a 
previously developed simple, facile, self-assembled approach is reported
7
. The data shows that 
the method previously developed can be used as a general approach to successfully synthesize 
protein-polymer conjugates by covalently linking the carboxyl functional groups of the anionic 
polymer to the amine containing lysine amino acids on the protein surface via amide bond 
formation through standard carbodiimide chemisrty (Scheme 1).  
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Scheme 2.1.  The synthesis schematic for the formation of the protein-polymer conjugates by 
linking the amino groups of the protein to the carboxyl groups of the polymer, PAA. The 
coupling agent used here is 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC). 
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 Previously it has been shown that conjugation of the proteins with this low molecular 
weight PAA (MW 8000) yields highly soluble, discrete nanoparticle formation which is resistant 
to steam sterilization
7
. It has also been shown that random cross-linking of high molecular 
weight PAA (MW 450,000) resulted in the formation of soluble nanogel networks. These 
nanogels showed streaking and particle precipitation in the wells of the agarose gels
8
. No 
streaking or precipitation was seen previously or shown presently with conjugation to the low 
molecular weight PAA. Also, these protein-polymer conjugates have shown significant activity 
retention after conjugation when compared to their unmodified counterparts. 
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2.3  Experimental 
2.3.1  Chemicals and Materials 
 Glucose Oxidase (GOx) and Lysozyme (Lys) were purchased from Sigma (St.Louis, 
MO). Catalase (Cat) was purchased from Worthington Biochemicals (Lakewood, NJ.  Protein 
solutions were prepared in the respective buffer solutions used for synthesis, as indicated, and the 
concentrations were deteremined from the absorbance of each protein using the appropriate 
extinction coefficient at 280 nm. The coupling agent used for synthesis, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), was purchased from TCI America (Portland, OR). 
Poly(acrylic acid) (PAA, 45 wt%, MW 8,000) was purchased from Sigma (St. Louis, MO). 
 
2.3.2  Protein-Polymer Conjugate Synthesis 
 The protein-polymer conjugates were synthesized by using EDC as the coupling agent 
with minor modifications to reported methods
9
. A mixture of 500 µL of 200 mM Na2HPO4 
buffer at pH 6, 7 or 8 with 270 µL of PAA (1 mmol) and 3730 µL of deionized water were added 
to a reaction vial, followed by sonication for 5 minutes. Next 100 mmol of EDC was added to the 
vial while stirring. The resulting PAA/EDC mixture was stirred for 5 minutes, followed by the 
addition of 500 µL of 100 µM protein (50 nmol) and stirred for 12 hours. Specific reaction 
conditions for each of the samples are summarized in Table 1. Excess EDC, PAA, and urea by-
product were dialyzed three times with 1000 times the sample volume with 25 kDa molecular 
weight cut off dialysis membrane to ensure pure protein-polymer conjugates. 
 The product obtained from the reaction of PAA (5000 nmol) with GOx (50 nmol) at pH 7 
(PAA to GOx mole ratio of 100:1) is designated as GOx-PAA(10)-7, while the reaction of 
50,000 nmol PAA with GOx (50 nmol) at pH 7 (PAA to Hb mole ratio of 1000:1) is designated 
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as GOx-PAA(1000)-7. This nomenclature will be used throughout the manuscript for unique 
identification of specific protein-polymer conjugate samples. Each sample has been centrifuged 
at 12,500 rpm and filtered using a 0.22 µm filter to remove invisible precipitates, if any. 
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Table 2.1.  Reaction conditions for the synthesis of protein-PAA conjugates from Catalase, 
Glucose Oxidase or Lysozyme (10 μM, 500 μL, 50 nmol) and EDC (100 mM, 95.8 mg, 500 
μmol) in sodium dibasic phosphate buffer, pH 7. 
 
Sample [PAA] 
(mM) 
PAA Vol 
(μL) 
Moles 
PAA 
Buffer Vol 
(μL) 
DI Vol 
(μL) 
Protein-PAA(100) 1 135 5 μmol 500 3865 
Protein-PAA(500) 5 675 25 μmol 500 3325 
Protein-PAA(1000) 10 1,350 50 μmol 500 2650 
Protein-PAA(1500) 15 2,025 75 μmol 500 1975 
Protein-PAA(2000) 20 2700 100 μmol 500 1300 
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2.3.3  Agarose Gel Electrophoresis 
 Agarose gels were prepared by dissolving molecular biology grade agarose (0.5% w/v) 
(Hoefer Inc., Holliston, MA) in a hot solution of Tris-Acetate (40 mM, pH 7.2). The gels were 
run in a horizontal gel electrophoresis apparatus (Gibco Model 200, Life Technologies Inc., 
Grand Island, NY) using Tris-Acetate (40 mM, pH 7.2) as the running buffer. Samples were 
loaded into the gel with loading buffer (50 % v/v glycerol and 0.01% m/m bromophenol blue) 
and electrophoresis carried out for 30 minutes at 100 V at room temperature. The gel was stained 
overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue and then destained with 10% 
v/v acetic acid for an additional night. The gels were photographed using a BioRad Chemidoc 
XRS+ (Hercules, CA). 
 
2.3.4  Spectral Measurements 
 Absorption spectra were recorded on an HP8453 uv-visible spectrophotometer (Agilent 
Technologies, Santa Clara, CA). The concentration of protein in solution was determined from 
the absorbance using the appropriate extinction coefficient at 280 nm (Table 2). All data was 
plotted using Kaleidagraph 4.1.1. 
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Table 2.2.  Summary of extinction coefficients used for various proteins. 
Protein Extinction Coefficient (M
-1
 cm
-1
) 
Catalase 420,000 
Glucose Oxidase 267,200 
Lysozyme 38,940 
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2.3.5  Enzymatic Activity Assays 
 For catalase, the decomposition of hydrogen peroxide (H2O2) was followed from reported 
methods
10
. Catalase (0.5 µM) was added to a solution of H2O2 (20 mM) and the disappearance of 
the H2O2 was monitored at 240 nm with respect to time at room temperature. 
 For glucose oxidase, the activity was determined by a previously reported method
11,12
. A 
solution of glucose (0.2 mM) was added to a mixture of GOx (0.5 µM), HRP (2 µM) and 
guaiacol (o-methoxyphenol) (10 mM) in DI water. Oxidation of the substrate, guaiacol, to a 
dimeric product (3,3’-dimethoxy-4,4’-biphenoquinone) which has absorption maxima at 470 nm 
was monitored as a function of time at room temperature. 
 For lysozyme, the rate of lysis of Micrococcus lysodeikticus cells is monitored as 
reported in the literature
13
. A suspension of M. Lysodeikticus cells (0.36 mg/mL) was placed in 
the spectrophotometer and a blank rate was estrablished by observing the absorbance at 450 nm 
with respect to time. Next, a solution of lysozyme (1 µM) was added to the cuvette and the rate 
of lysis of the cell walls was established. All enzymatic activity data was plotted using 
Kaleidagraph v4.1.1. 
 
2.4  Results and Discussion 
 Here, the successful synthesis of various protein-polymer conjuagtes using various 
proteins with low molecular weight PAA (MW 8,000) is reported. Previously it has been shown 
that hemoglobin (Hb) shows activity retention after steam sterilization, using this technology
7
. It 
has also been previously shown that covalent conjugation of Hb to high molecular weight PAA 
(MW 450,000) resulted in the formation of nanogels. These nanogels did not show the same 
 69 
  
activity retention after steam sterilization
8
. Herein the successful synthesis and initial enzymatic 
activity studies for the small library produced are reported. 
 
2.4.1  Protein-Polymer Conjugate Synthesis 
 Proteins are large, polyfunctional, biological macromolecules with a large variety of 
surface functional groups, including amines and carboxyl moieties. Previously, the amine groups 
of the surface lysine side chains have been modified with a large variety of carboxyl group 
containing substrates via standard carbodiimide chemistry
14
. Using a similar strategy here, a 
large excess of PAA (MW 8000, 100 or 1000 molar excess) was covalently attached to the 
surface lysine side chains of the proteins using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
as the coupling agent. After synthesis, all of the conjugates produced remained completely 
soluble, with no precipitation or nanogel formation. The protein/EDC/PAA reaction mixture was 
allowed to react for 12 hours, followed by dialysis with a 25 kDa molecular weight cut off 
dialysis membrane to remove any excess PAA, EDC and urea by product.  
 
2.4.2  Agarose Gel Electrophoresis 
 Covalent attachment of PAA to the proteins is expected to give rise to negatively charged 
protein-polymer conjugates like we have shown before
7
. At pH 7.2, each of these proteins have 
different net charges. Amylase, Catalase, and Glucose Oxidase all have net negative charges, 
while Lysozyme has a net positive charge. Thusly, conjugation of the PAA to the various 
proteins is expected to greatly increase the electrophoretic mobilities of Lysozyme much more 
than that of Amylase, Catalase, or Glucose Oxidase. 
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 As predicted, the Cat-PAA conjugates (100-2,000 fold excess PAA per Catalase) moved 
further towards the positive electrode than did the unmodified Catalase sample (Figure 1). This 
increase in migration is not due to the physical binding of the PAA to the protein, as no change 
in migration between the unmodified Catalase sample and the physical mixture (not shown). The 
presence of new bands and the absence of the catalase band in lanes 1-5 indicate the complete 
conversion of catalase to the Cat-PAA conjugates. In comparison to previously published low 
molecular weight Hb-PAA conjugates
7
, a similar result has been observed with the conjugation 
of catalase with PAA to form Cat-PAA conjugates. In contrast, it has been previously shown that 
the nanogel networks formed between the Hb and high molecular weight PAA (MW 450,000) 
moved as streaks on the agarose gels under the same electrophoresis conditions
8
. Thusly, it has 
been shown that the technology previously developed with the Hb-PAA conjugates can be 
applied to other proteins and enzymes to form the corresponding protein/enzyme-PAA 
conjugates.  
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Figure 2.1. Agarose gel of Catalase (lane 6), Cat-PAA(100) (lane 5), Cat-PAA(500) (lane 4), 
Cat-PAA(1000) (lane 3), Cat-PAA(1500) (lane 2) and Cat-PAA(2000) (lane 1). The conjugates 
used here were synthesized at pH 8. All samples were spotted in the center of the gel (0.5% 
agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30 min at 100V. The unmodified 
catalase did not migrate far from the center of the gel, towards the positive electrode. The Cat-
PAA conjugates all migrated further towards the positive electrode and do not show any 
unreacted catalase in the lanes. 
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Conjugates were also prepared with glucose oxidase (100-2,000 fold molar excess PAA) 
and saw similar results to those of the catalase conjuagtes mentioned before. The increase in 
electrophoretic mobility is again due to the covalent attachment of the PAA. The loss of the band 
for unmodified glucose oxidase and the presence of a new band (Figure 2, lanes 2-11) indicate 
the complete conversion to the GOx-PAA conjuagtes. This again agrees with our general 
approach to synthesize protein-polymer conjugates through a covalent, self-assembled method. 
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Figure 2.2.  Agarose gel of GOx (lanes 1 and 12) and GOx-PAA conjuagtes (lanes 2-11). The 
unmodified GOx in lanes 1 and 12 show two distinct bands because the protein sample consists 
of the monomer and dimer forms of GOx. The conjugates on this gel were synthesized at pH 6 
and 7. The lanes consist of GOx-PAA(100) (lane 11, pH 6; lane 10, pH 7), GOx-PAA(500) (lane 
9, pH 6; lane 8, pH 7), GOx-PAA(1000) (lane 7, pH 6; lane 6, pH 7), GOx-PAA(1500) (lane 5, 
pH 6; lane 4, pH 7) and GOx-PAA(2000) (lane 3, pH 6; lane 2, pH 7). All samples were spotted 
in the center of the gel (0.5% agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30 
min at 100 V. The GOx-PAA samples migrated further toward the negative electrode than the 
unmodified GOx samples, retaining the two band shape of the unmodified samples, thus there is 
no unreacted GOx in the lanes. 
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 Conjugates prepared from lysozyme and the low molecular weight PAA (100-2,000 
molar excess) behaved similarly to the two sets of conjugates previously mentioned. Again, 
using our general approach to prepare the protein-polymer conjugates, it is confirmed that the 
increase seen in the electrophoretic mobility is due to the covalent conjugation of the PAA to the 
lysozyme (Figure 3). Further, there is no indication of free lysozyme in the lane with the 
conjugate, indicating the complete conversion of the enzyme to the conjugate form. 
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Figure 2.3.  Agarose gel of lysozyme (lane 2) and Lys-PAA(100)-7 (lane 1). The unmodified 
lysozyme migrated towards the negative electrode, which means that the unmodified lysozyme 
has a net positive charge. The Lys-PAA(100) migrated towards the positive electrode and do not 
show any unreacted lysozyme in the lane. The samples were spotted in the center of the gel 
(0.5% agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30 min at 100 V. 
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The average pore size of the agarose gels used in Figures 1-3 (0.5% gel) is around 450 
nm, and all of the protein-polymer conjugates moved through the gel readily. Thus, it can be 
assumed that the conjuagtes are all much smaller than 450 nm in diameter. It can also be 
assumed that there is no formation of any nanogel networks, which would have been indicated 
by streaks on the gels instead of clearly defined bands
8
. This is consistent with the observations 
of highly soluble conjugates and the low overlap concentration of the PAA
15
. The agarose gels 
confirm the clean and consistent linking of the PAA to the proteins. 
 
2.4.3  Enzymatic Activity Assays 
 The catalytic activity of catalase was monitored by the decomposition of hydrogen 
peroxide (substrate) by its decreasing absorption at 240 nm as a function of time (Figure 4). The 
decomposition of H2O2 by catalase (blue curve) and Cat-PAA(1000)-8 (green curve) are almost 
identical and PAA by itself did not catalyze the reaction (data not shown). The initial rates of the 
conjugate sample were compared to the initial rates of the unmodified catalase and about 12 % 
increase in activity of Cat-PAA was observed when compared to the unmodified catalase, but 
this increase is within the experimental errors. 
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Figure 2.4.  The decomposition activity of hydrogen peroxide by catalase (blue curve) and Cat-
PAA(1000)-8 (green curve). All activity data was measured at room temperature in the presence 
of 0.5 µM protein and 20 mM H2O2 in 20 mM Na2HPO4, pH 7.2. 
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 The enzymatic activities of glucose oxidase were also measured by following procedures 
reported in literature
11,12
. The oxidation of a peroxidase substrate to a dimeric product was 
monitored at 470 nm as a function of time at room temperature. The activities of the GOx-PAA 
conjugates were very similar to that of the unmodified GOx. When comparing the relative 
activities, the conjugates showed significant activities, most being close to that of GOx, with the 
lowest having 86% activity retention. 
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Figure 2.5. (a) Kinetics traces for GOx (red curve) and GOx-PAA conjugate samples (glucose 
(0.2 mM), GOx (0.5 µM), HRP (2 µM) and guaiacol (10 mM) in 20 mM Na2HPO4, pH 7.2). (b) 
Comparison of relative activities of the GOx-PAA conjugates with that of the unmodified GOx 
at room temperature under the same reaction conditions. 
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In order to determine the activities of lysozyme, the rate of lysis of the cell walls of M. 
lysodeikticus cells was used. A solution of lysozyme (1 µM) was added to a suspension of M. 
lysodeikticus cells (0.36 mg/mL) and the change in absorbance at 450 nm was monitored as a 
function of time. The lysozyme was injected after 100 seconds of monitoring the absorbance to 
establish a blank rate, if any, and the kinetic traces are compared below in Figure 6. Here a major 
difference between the two curves. After the point of lysozyme/Lys-PAA(100)-6 injection (100 
sec) the red curve begins to decrease immediately at a steady rate (-6.84 x 10
-4
 µM
-1
 s
-1
), while 
the blue curve does not decrease. This is because the cells are too large to gain access to the 
lysozyme protein inside of the conjugates. We hypothesize that the pore size of the polymer shell 
around the protein is much smaller than the diameter of the M. lysodeikticus cells, thus the cell 
wall will not be lysed and no change in absorbance will be observed.  
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Figure 2.6.  Kinetic traces for Lysozyme (red curve) and Lys-PAA(100)-6 (blue curve). Activity 
data was collected in a solution of M. lysodeikticus cells (0.36 mg/mL) and lysozyme (1 µM) in 
20 mM Na2HPO4, pH 7.2 at room temperature. 
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2.5  Conclusions 
 Covalent conjugation of polymers with proteins is providing new and exciting 
opportunities in biomaterials. However, limited progress has been made in this field due to very 
few polymers being used, such as polyethylene glycol, which has a limited number of functional 
groups. Previously, a simple, modular, self-assembled approach of covalent conjugation of low 
molecular weight PAA (MW 8,000), a multifunctional, hydrophilic polymer to the surface lysine 
amino acids of Hb has been reported. These bioconjugates were produced with controlled size, 
solubility, improved thermal stabilities and near-reversible denaturation
7
. Here, the use of the 
previously optimized technology to synthesize new, discrete nanoparticles with other various 
proteins is reported. 
 Based on the agarose gel electrophoresis, it can be suggested that discrete nanoparticles 
are formed through the covalent conjugation of the low molecular weight PAA (MW 8,000) to 
the protein surface lysine groups. Nanogel network formation is not observed because they are 
no streaks observed in the agarose gel, nor is there any precipitation in the wells. 
 Based on the activity data for the conjugates made with catalase and glucose oxidase, the 
newly formed conjugates are endowed with the biological activities of their respective 
unmodified proteins, showing significant activity retention after conjugation. However, in the 
case of the conjugates made with lysozyme the biological activities of the proteins post-
modification cannot be determined because the Micrococcus lysodeikticus cells (substrate) are 
too large to pass through the pores of the polymer shell. 
 Overall, previously developed methods were used to create a small library of protein-
polymer conjugates. These are welcome for applications in biocatalysis and biomaterials due to 
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the discrete particle formation and significant activity retention. These results currently add to 
the idea that one day, protein-polymer biomaterials will be used in biosensors, protein 
therapeutics if tailored to the proper conditions. 
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